2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
22
Leukemia
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Myelodysplastic Syndromes
17
Lymphoma
14
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Multiple Myeloma
10
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, Non-Hodgkin
7
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Hematologic Neoplasms
5
Hematologic Diseases
5
Neuroblastoma
4
Graft vs Host Disease
4
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Neoplasms, Plasma Cell
3
Neoplasms
3
Myeloproliferative Disorders
3
Lymphoma, Follicular
3
Leukemia, Myeloid
3
Leukemia, Lymphoid
3
Congenital Abnormalities
3
Burkitt Lymphoma
3
Brain Neoplasms
3
Wilms Tumor
2
Waldenstrom Macroglobulinemia
2
Testicular Neoplasms
2
Sarcoma
2
Interventions
Ifosfamide
30
Methotrexate
29
Doxorubicin
26
Cyclophosphamide
24
Cisplatin
22
Filgrastim
18
Etoposide
17
Gemcitabine
16
Leucovorin
14
Magnetic Resonance Spectroscopy
11
Temozolomide
10
Specimen Handling
10
cabozantinib
9
apatinib
9
X-Rays
9
Carboplatin
9
fludarabine
8
Radiotherapy
8
Nivolumab
8
Neoadjuvant Therapy
8
Irinotecan
8
Granulocyte Colony-Stimulating Factor
8
Drug Therapy
8
Docetaxel
8
Zoledronic Acid
7
Vincristine
7
Sirolimus
7
Phantoms, Imaging
7
Biopsy
7
mifamurtide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Bone Marrow Transplantation
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts